Trial Profile
A Non-Interventional Safety Study Providing 12 Months Follow-up From First Exposure to HP802-247 in Subjects With Venous Leg Ulcer [EXTENSION OF 700240861]
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 10 Feb 2014
Price :
$35
*
At a glance
- Drugs HP 802247 (Primary)
- Indications Varicose ulcer
- Focus Adverse reactions
- Sponsors Smith & Nephew Biotherapeutics
- 10 Feb 2014 Planned End Date changed to 1 May 2015.
- 10 Feb 2014 New trial record